XML 24 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Total Revenue $ 26,544 $ 11,236 $ 0
Operating expenses:      
Research and development 25,312 29,191 24,663
General and administrative 29,393 14,302 12,208
Restructuring charge 5,528 0 0
Intangibles impairment charge 31,700 0 0
Change in fair value of contingent consideration (56,840) (11,180) 71,620
Total operating expenses 35,093 32,313 108,491
Loss from Operations (8,549) (21,077) (108,491)
Other (expense) income, net (60) 125 991
Loss Before Taxes (8,609) (20,952) (107,500)
Benefit (provision) from income taxes 8,273 (1,445) 0
Net Loss After Taxes (336) (22,397) (107,500)
Comprehensive Loss After Taxes (336) (22,397) (107,500)
Deemed dividend on adjustment of exercise price of certain warrants 0 (147) 0
Net loss attributable to common stockholders - basic (336) (22,544) (107,500)
Net loss attributable to common stockholders - diluted $ (336) $ (22,544) $ (107,500)
Net loss per common share - basic (in dollars per share) $ 0 $ (0.19) $ (1.18)
Net loss per common share - diluted (in dollars per share) $ 0 $ (0.19) $ (1.18)
Weighted-average common shares outstanding - basic (in shares) 182,323 118,221 90,929
Weighted-average common shares outstanding for diluted (in shares) 182,323 118,221 90,929
License and related revenue      
Total Revenue $ 26,544 $ 11,236 $ 0